|
FY2025
12 months to Dec 31, 2025
|
FY2024
7 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Payment of formation and operating costs through promissory note – related party | ||
| Interest earned on investments held in Trust Account | ||
| Compensation expense | ||
| Changes in operating assets and liabilities: | ||
| Accrued expenses | ||
| Prepaid expenses | ||
| Long-term prepaid expenses | ||
| Due to officer | ||
| Accounts payable and accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of founder shares | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of private placements units | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-cash investing and financing activities: | ||
| Deferred offering costs paid through promissory note – related party | ||
| Deferred underwriting fee payable | ||
| Deferred offering costs included in accrued offering costs |
Loading...
